Literature DB >> 25833777

A high-glycemic index, low-fiber breakfast affects the postprandial plasma glucose, insulin, and ghrelin responses of patients with type 2 diabetes in a randomized clinical trial.

Flávia M Silva1, Caroline K Kramer1, Daisy Crispim1, Mirela J Azevedo2.   

Abstract

BACKGROUND: Meals with a low glycemic index (GI) and rich in fiber could be beneficial with regard to postprandial metabolic profile and satiety.
OBJECTIVE: The aim of this study was to investigate the effect of 4 breakfasts with a different GI and amount of fiber on postprandial plasma glucose, insulin, and appetite in patients with type 2 diabetes.
METHODS: This randomized 4-intervention crossover trial included 14 patients [7 men; ages 65.8 ± 5.2 y; glycated hemoglobin: 6.6 ± 0.9%; BMI (in kg/m(2)): 27.2 ± 3.1]. Dietary interventions were as follows: breakfasts with a high GI (60.4 ± 0.1%) and high fiber (6.0 ± 0.3 g) (HGI-HF), a high GI (60.9 ± 1.7%) and low fiber (2.5 ± 0.4 g) (HGI-LF), a low GI (37.7 ± 0.1%) and high fiber (6.2 ± 0.3 g) (LGI-HF), and a low GI (39.8 ± 1.3%) and low fiber (2.0 ± 0.1 g) (LGI-LF). Plasma glucose, insulin, and total ghrelin were evaluated postprandially (0-180 min). A visual analog scale was used to assess appetite. Data were analyzed by generalized estimating equations and post hoc least significant difference (LSD) tests. Data are reported as means ± SDs.
RESULTS: The area under the curve (AUC) [mean (95% CI); P for LSD tests] for plasma glucose (mmol/L × min) was higher after patients consumed the HGI-LF breakfast [9.62 (8.39, 10.84)] than after the LGI-HF breakfast [8.95 (7.71, 10.18)] (P ≤ 0.05). Insulin AUC (μIU/mL × min) after patients consumed the HGI-LF meal [65.72 (38.24, 93.19)] was higher than after the HGI-HF meal [57.24 (32.44, 82.04)] (P ≤ 0.05). The other observed difference was higher insulin AUC after the consumption of the LGI-LF breakfast [61.54 (36.61, 86.48)] compared with the AUC after the LGI-HF breakfast [54.16 (31.43, 76.88)] (P ≤ 0.05). Plasma ghrelin decreased in comparison with baseline only after patients consumed the LGI-HF and LGI-LF breakfasts (P ≤ 0.05). Subjective satiety did not differ between breakfasts.
CONCLUSIONS: Plasma glucose, insulin, and ghrelin responses were least favorable when patients with type 2 diabetes consumed a breakfast with a high GI and low fiber, which suggests that reducing the GI or increasing the fiber content or both of breakfasts may be a useful strategy to improve the postprandial metabolic profile of these patients. This trial was registered at clinicaltrials.gov as NCT01410292.
© 2015 American Society for Nutrition.

Entities:  

Keywords:  diabetes; dietary fiber; glycemic index; plasma ghrelin; plasma glucose

Mesh:

Substances:

Year:  2015        PMID: 25833777     DOI: 10.3945/jn.114.195339

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  14 in total

1.  Durum wheat particle size affects starch and protein digestion in vitro.

Authors:  Giuseppina Mandalari; Zara Merali; Peter Ryden; Simona Chessa; Carlo Bisignano; Davide Barreca; Ersilia Bellocco; Giuseppina Laganà; Richard M Faulks; Keith W Waldron
Journal:  Eur J Nutr       Date:  2016-10-26       Impact factor: 5.614

Review 2.  Nutritional Modulation of the Microbiome and Immune Response.

Authors:  Ansen H P Burr; Amrita Bhattacharjee; Timothy W Hand
Journal:  J Immunol       Date:  2020-09-15       Impact factor: 5.422

Review 3.  Novel trends and concepts in the nutritional management of glycemia in type 2 diabetes mellitus-beyond dietary patterns: a narrative review.

Authors:  Zoe Pafili; Charilaos Dimosthenopoulos
Journal:  Hormones (Athens)       Date:  2021-08-29       Impact factor: 2.885

4.  Orange Pomace Improves Postprandial Glycemic Responses: An Acute, Randomized, Placebo-Controlled, Double-Blind, Crossover Trial in Overweight Men.

Authors:  C-Y Oliver Chen; Helen Rasmussen; Alison Kamil; Peng Du; Jeffrey B Blumberg
Journal:  Nutrients       Date:  2017-02-13       Impact factor: 5.717

Review 5.  The Gastrointestinal Tract as an Integrator of Mechanical and Hormonal Response to Nutrient Ingestion.

Authors:  Adrian Vella; Michael Camilleri
Journal:  Diabetes       Date:  2017-11       Impact factor: 9.461

6.  Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: Latin American subpopulation analysis of a randomized trial.

Authors:  Arturo Rojas; Georgina Sposetti; Jorge L Gross; Douglas Eugenio Barbieri; Ran Duan; Bruno Linetzky; Janaina Martins De Lana; Oded Stempa; Angel Rodriguez
Journal:  Diabetol Metab Syndr       Date:  2016-09-17       Impact factor: 3.320

7.  Low-Glycemic-Index/Load Desserts Decrease Glycemic and Insulinemic Response in Patients with Type 2 Diabetes Mellitus.

Authors:  Vasiliki Argiana; Panagiotis Τ Kanellos; Ioanna Eleftheriadou; Georgios Tsitsinakis; Despoina Perrea; Nikolaos K Tentolouris
Journal:  Nutrients       Date:  2020-07-20       Impact factor: 5.717

Review 8.  Relevance of the Glycemic Index and Glycemic Load for Body Weight, Diabetes, and Cardiovascular Disease.

Authors:  Sonia Vega-López; Bernard J Venn; Joanne L Slavin
Journal:  Nutrients       Date:  2018-09-22       Impact factor: 5.717

9.  Effect of transcranial direct current stimulation associated with hypocaloric diet on weight loss and metabolic profile in overweight or obesity: study protocol for a double-blind, randomized controlled clinical trial.

Authors:  Carina de Araujo; Raquel Crespo Fitz; Daniela Albugeri Nogara; Pedro Schestatsky; Fernando Gerchman
Journal:  Trials       Date:  2018-07-16       Impact factor: 2.279

10.  Associations between maternal dietary patterns and infant birth weight, small and large for gestational age in the Norwegian Mother and Child Cohort Study.

Authors:  Linda Englund-Ögge; Anne Lise Brantsæter; Julius Juodakis; Margareta Haugen; Helle Margrete Meltzer; Bo Jacobsson; Verena Sengpiel
Journal:  Eur J Clin Nutr       Date:  2018-11-20       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.